Workflow
西麦食品(002956):公司信息更新报告:2024年收入稳步增长,2025年利润弹性有望释放
开源证券· 2025-04-28 05:53
食品饮料/休闲食品 西麦食品(002956.SZ) 2024 年收入稳步增长,2025 年利润弹性有望释放 2025 年 04 月 28 日 投资评级:增持(维持) | 日期 | 2025/4/25 | | --- | --- | | 当前股价(元) | 18.59 | | 一年最高最低(元) | 19.88/10.09 | | 总市值(亿元) | 41.50 | | 流通市值(亿元) | 41.50 | | 总股本(亿股) | 2.23 | | 流通股本(亿股) | 2.23 | | 近 3 个月换手率(%) | 138.29 | 股价走势图 数据来源:聚源 -40% -20% 0% 20% 40% 60% 2024-04 2024-08 2024-12 西麦食品 沪深300 相关研究报告 《员工持股计划落地,立足中长期稳 健发展 — 公 司 信 息 更 新 报 告 》 -2025.2.20 《春节销售预期乐观,成本改善释放 利 润 弹 性 — 公 司 信 息 更 新 报 告 》 -2024.12.26 《业绩稳步增长,线上渠道主动调控 —公司信息更新报告》-2024.11.3 张宇光(分析师) 张恒玮(分 ...
英科医疗(300677):公司信息更新报告:2024年业绩高增,剑指全球手套龙头
开源证券· 2025-04-28 05:52
医药生物/医疗器械 英科医疗(300677.SZ) 2024 年业绩高增,剑指全球手套龙头 2025 年 04 月 28 日 投资评级:买入(维持) | 日期 | 2025/4/25 | | --- | --- | | 当前股价(元) | 22.38 | | 一年最高最低(元) | 33.61/19.78 | | 总市值(亿元) | 144.62 | | 流通市值(亿元) | 104.99 | | 总股本(亿股) | 6.46 | | 流通股本(亿股) | 4.69 | | 近 3 个月换手率(%) | 126.91 | 股价走势图 数据来源:聚源 -32% -16% 0% 16% 32% 2024-04 2024-08 2024-12 英科医疗 沪深300 相关研究报告 《全球丁腈手套龙头,精益成本管理& 海外建厂扩产筑建强大护城河—公司 深度报告》-2025.2.27 ——公司信息更新报告 | 余汝意(分析师) | 司乐致(分析师) | 石启正(联系人) | | --- | --- | --- | | yuruyi@kysec.cn | silezhi@kysec.cn | shiqizheng@kyse ...
仙琚制药(002332):诺泰生物(688076)2024年年报及2025年一季报点评:短期业绩承压蓄势,新品迭代构建增长新范式
民生证券· 2025-04-28 05:52
仙琚制药(688076.SH)2024 年年报及 2025 年一季报点评 短期业绩承压蓄势,新品迭代构建增长新范式 2025 年 04 月 28 日 ➢ 拆分:制剂业务收入维持稳健增长,原料药价格下探致使收入下滑。根据年报,公司 24 年制剂业务收入 24.2 亿元(同比+6.0%),毛利率 76.3%(同比+3.0pct);原料药 业务收入 15.5 亿元(同比-13.4%),毛利率 28.9%(同比+2.7pct)。进一步拆分上看, 公司制剂业务增速放缓主要系普药和妇科两大业务线的相关品种纳入省级联盟集采(收入 端:普药同比-19.0%,妇科持平);原料药业务收入下滑主要系非规市场价格下滑+规范 市场去库存等因素叠加(收入端:自营原料药同比-1.0%,意大利子公司-13.1%)。 ➢ 制剂:呼吸、皮肤稳健放量,麻醉肌松集采创伤后回暖。根据年报,公司 24 年自营 制剂产品收入 22.8 亿元,同比上升 8.0%。主要制剂产品收入按领域分拆来看,妇科计生 /麻醉肌松/呼吸/皮肤/普药实现收入 4.5/1.6/8.8/2.3/5.5 亿元,分别同比持平 /+55%/+31%/+19%/-19%。呼吸及皮肤成为 ...
金科环境(688466):2024年报、2025一季报点评:25Q1业绩同增33%,AI产品化升级、工业应用场景持续拓展
东吴证券· 2025-04-28 05:47
证券研究报告·公司点评报告·环境治理 金科环境(688466) 2024 年报&2025 一季报点评:25Q1 业绩同 增 33%,AI 产品化升级&工业应用场景持续 拓展 买入(维持) | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入(百万元) | 572.76 | 617.11 | 711.33 | 816.73 | 934.36 | | 同比(%) | (14.63) | 7.74 | 15.27 | 14.82 | 14.40 | | 归母净利润(百万元) | 70.77 | 66.79 | 85.55 | 103.54 | 124.53 | | 同比(%) | (7.83) | (5.62) | 28.08 | 21.03 | 20.28 | | EPS-最新摊薄(元/股) | 0.57 | 0.54 | 0.69 | 0.84 | 1.01 | | P/E(现价&最新摊薄) | 27.02 | 28.63 | 22.35 | 18 ...
贝泰妮(300957):业绩短暂承压,彩妆业务增速亮眼
天风证券· 2025-04-28 05:43
Investment Rating - The investment rating for the company is "Buy" with a target price not specified [5] Core Views - The company experienced a temporary pressure on performance, but the makeup business showed remarkable growth [1] - The skincare segment's revenue decreased by 1.41% year-on-year, while the makeup segment's revenue surged by 226.48% [3] - The company is focusing on multi-brand development with Winona as the core brand, aiming to enhance customer value through a combination strategy of single products and sets [4] Financial Performance Summary - For 2024, the company reported a revenue of 5.736 billion yuan, a year-on-year increase of 3.87%, and a net profit attributable to the parent company of 503 million yuan, a decrease of 33.53% [1] - The gross profit margin for 2024 was 73.74%, a slight decrease of 0.16 percentage points year-on-year [2] - The company’s revenue for Q1 2025 was 949 million yuan, down 13.51% year-on-year, with a net profit of 28 million yuan, down 83.97% [1] Segment Performance Summary - The skincare segment accounted for 83.70% of total revenue in 2024, while the makeup segment contributed 9.60% [3] - Online sales increased by 10.13% year-on-year, representing 68.21% of total revenue, while offline sales decreased by 10.72% [3] Future Projections - Revenue projections for 2025-2027 are 6.335 billion, 7.260 billion, and 8.491 billion yuan respectively, with net profits of 760 million, 923 million, and 1.057 billion yuan [4] - The company is expected to maintain a stable position in the market while exploring overseas expansion [4]
云赛智联(600602):2024年年报和2025年一季报点评:上海算力建设风来,算力领军云赛启航
东吴证券· 2025-04-28 05:33
证券研究报告·公司点评报告·软件开发 2025 年 04 月 28 日 证券分析师 王紫敬 云赛智联(600602) 2024 年年报和 2025 年一季报点评:上海算 力建设风来,算力领军云赛启航 买入(维持) | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入(百万元) | 5,264 | 5,623 | 6,380 | 7,110 | 7,908 | | 同比(%) | 16.09 | 6.82 | 13.47 | 11.44 | 11.23 | | 归母净利润(百万元) | 192.91 | 202.39 | 222.17 | 243.89 | 262.18 | | 同比(%) | 6.70 | 4.92 | 9.77 | 9.78 | 7.50 | | EPS-最新摊薄(元/股) | 0.14 | 0.15 | 0.16 | 0.18 | 0.19 | | P/E(现价&最新摊薄) | 161.36 | 153.80 | 140.11 ...
迈信林(688685):公司动态研究报告:业绩快速高增,算力业务打造第二成长极
华鑫证券· 2025-04-28 05:32
业绩快速高增,算力业务打造第二成长极 买入(维持) 投资要点 分析师:宝幼琛 S1050521110002 baoyc@cfsc.com.cn 2025 年 04 月 28 日 —迈信林(688685.SH)公司动态研究报告 ▌算力综合业务初见成效,为公司的持续发展提供 有力支撑。 2024 年 9 月,公司为进一步拓展业务领域,引入战略投资者 白冰先生与徐迎辉先生。白冰先生所创立的光子算数(北 京)科技有限责任公司专注于光互联算力集群系统的构建、 交付与运营,徐迎辉先生及其团队在国产算力中心机房建 设、配套采购、客户服务层面有着较大的优势。双方一致同 意通过控股股东、实际控制人张友志先生转让 10.00%股权, 白冰先生与徐迎辉先生各受让 5.00%股权来达成合作,共同推 动上市公司战略发展。 | 基本数据 | 2 0 2 5-0 4-2 5 | | --- | --- | | 当前股价(元) | 65.15 | | 总市值(亿元) | 95 | | 总股本(百万股) | 145 | | 流通股本(百万股) | 145 | | 52 周价格范围(元) | 21.75-69.25 | | 日均成交额(百万元) ...
迪威尔:新项目按期推进,深海产品景气上行-20250428
华泰证券· 2025-04-28 05:30
证券研究报告 迪威尔 (688377 CH) 新项目按期推进,深海产品景气上行 | 华泰研究 | | 年报点评 | | --- | --- | --- | | 2025 年 4 月 | 27 日│中国内地 | 专用设备 | 公司公布 24 年与 25 年 Q1 业绩:24 年收入 11.24 亿元,同比-7.12%;归 母净利润 0.86 亿元,同比-39.90%。25 年 Q1 收入 2.71 亿元,同比-5.36%; 归母净利润 0.21 亿元,同比-25.40%。公司年报业绩低于我们预期(预期 归母净利 1.04 亿元),主要系油气生产系统专用件业务增速不及预期。24 年海上油气资本开支有所回落拖累公司收入端,但 25 年公司募投项目投产 后有望打开新的市场空间,公司业绩订单有望释放。维持"买入"评级。 产品结构调整,毛利率稍有承压 24 年公司毛利率 18.80%,同比-3.18 pp,主要系下游油气项目延缓,公司 深海产品销售占比下降。但公司堆焊、精加工订单增长明显,提升产品附加 值,盈利端有望逐步改善。25Q1 单季度毛利率 18.96 %,同比/环比-0.54 pp/+0.62pp。期间费用率方 ...
陕西煤业:盈利相对稳健,红利逻辑凸显-20250428
华泰证券· 2025-04-28 05:30
Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 28.36 [7][8]. Core Views - The company's profitability remains relatively stable, supported by a strong cash flow that underpins high dividends, highlighting a robust dividend logic [1]. - The company benefits from high electricity prices in Shaanxi, which supports stable long-term coal prices, enhancing its profitability compared to industry peers [2]. - The coal business is focused on cost reduction and volume growth, with significant increases in coal production and sales driven by trade coal sales [3]. - The report has adjusted the profit forecasts for 2025-2026, reflecting a decrease in expected net profit due to lower coal prices, but maintains a positive outlook on the company's ability to sustain high dividends [4]. Summary by Sections Financial Performance - In 2024, the company recorded operating revenue of RMB 184.145 billion, a year-on-year increase of 1.47%, and a net profit attributable to shareholders of RMB 22.36 billion, a decrease of 3.21% [1]. - For Q1 2025, the operating revenue was RMB 40.162 billion, down 7.30% year-on-year, with a net profit of RMB 4.805 billion, down 1.23% [1]. Production and Sales - The company achieved a raw coal production of 170 million tons in 2024, up 4.1% year-on-year, and sales of 258 million tons, up 9.13% year-on-year, primarily driven by trade coal sales [3]. - The average cost of selected coal was RMB 289.92 per ton, a decrease of 2.25% year-on-year, due to reductions in material costs and maintenance expenses [3]. Profit Forecast and Valuation - The report projects net profits of RMB 21.15 billion for 2025 and RMB 21.90 billion for 2026, with corresponding EPS of RMB 2.18 and RMB 2.26 [4]. - The target price has been adjusted to RMB 28.36, based on a 13x PE valuation for 2025, compared to an industry average of 8.7x [4].
滨江集团(002244):2024年报点评:销售排名稳步提升,业绩实现逆市增长
东吴证券· 2025-04-28 05:27
证券研究报告·公司点评报告·房地产开发 滨江集团(002244) 2024 年报点评:销售排名稳步提升,业绩实 现逆市增长 买入(维持) | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入(百万元) | 70,443 | 69,152 | 69,982 | 65,713 | 67,750 | | 同比(%) | 69.73 | (1.83) | 1.20 | (6.10) | 3.10 | | 归母净利润(百万元) | 2,529 | 2,546 | 2,799 | 3,021 | 3,321 | | 同比(%) | (32.41) | 0.66 | 9.94 | 7.95 | 9.92 | | EPS-最新摊薄(元/股) | 0.81 | 0.82 | 0.90 | 0.97 | 1.07 | | P/E(现价&最新摊薄) | 12.29 | 12.21 | 11.11 | 10.29 | 9.36 | [Table_Tag] [Table_ ...